- Home
- BTAI vs ONMD Comparison
BTAI vs ONMD Comparison
Compare BTAI & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BTAI
- ONMD
- Stock Information
- Founded
- BTAI 2017
- ONMD 2006
- Country
- BTAI United States
- ONMD United States
- Employees
- BTAI N/A
- ONMD N/A
- Industry
- BTAI Biotechnology: Pharmaceutical Preparations
- ONMD
- Sector
- BTAI Health Care
- ONMD
- Exchange
- BTAI Nasdaq
- ONMD Nasdaq
- Market Cap
- BTAI 28.7M
- ONMD 23.9M
- IPO Year
- BTAI 2018
- ONMD N/A
- Fundamental
- Price
- BTAI $0.36
- ONMD $0.97
- Analyst Decision
- BTAI Strong Buy
- ONMD
- Analyst Count
- BTAI 4
- ONMD 0
- Target Price
- BTAI $5.00
- ONMD N/A
- AVG Volume (30 Days)
- BTAI 949.6K
- ONMD 264.3K
- Earning Date
- BTAI 11-14-2024
- ONMD 12-31-2024
- Dividend Yield
- BTAI N/A
- ONMD N/A
- EPS Growth
- BTAI N/A
- ONMD N/A
- EPS
- BTAI N/A
- ONMD N/A
- Revenue
- BTAI $2,276,000.00
- ONMD $957,031.00
- Revenue This Year
- BTAI $164.86
- ONMD N/A
- Revenue Next Year
- BTAI $69.74
- ONMD N/A
- P/E Ratio
- BTAI N/A
- ONMD N/A
- Revenue Growth
- BTAI 83.25
- ONMD 14.75
- 52 Week Low
- BTAI $0.35
- ONMD $0.42
- 52 Week High
- BTAI $4.17
- ONMD $3.37
- Technical
- Relative Strength Index (RSI)
- BTAI 32.49
- ONMD 54.64
- Support Level
- BTAI $0.35
- ONMD $0.90
- Resistance Level
- BTAI $0.52
- ONMD $0.98
- Average True Range (ATR)
- BTAI 0.06
- ONMD 0.15
- MACD
- BTAI -0.00
- ONMD -0.01
- Stochastic Oscillator
- BTAI 2.92
- ONMD 28.13
About BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About ONMD OneMedNet Corp
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.